(Q33984216)

30 July 2017

title

Pharmacokinetics of mycophenolic acid in patients with lupus nephritis (English)

1 reference

30 July 2017

1 reference

Melanie S Joy

1

1 reference

30 July 2017

Tandrea Hilliard

2

1 reference

30 July 2017

Yichun Hu

3

1 reference

30 July 2017

Susan L Hogan

4

1 reference

30 July 2017

Mary Anne Dooley

5

1 reference

30 July 2017

Ronald J Falk

6

1 reference

30 July 2017

Philip C Smith

7

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

30 July 2017

1 reference

30 July 2017

volume

29

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

7-16

1 reference

Emerging evidence of the impact of kidney disease on drug metabolism and transport

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901907

Mechanism-based concepts of size and maturity in pharmacokinetics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901907

Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901907

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901907

Regulation of drug-metabolizing enzymes and transporters in inflammation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901907

Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901907

The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901907

Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901907

Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901907

Clinical pharmacokinetics of mycophenolate mofetil

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901907

Prediction of creatinine clearance from serum creatinine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901907

Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients.

5 July 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.7

Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.7

The safety and efficacy of MMF in lupus nephritis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.7

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.7

The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.7

Pharmacokinetics of mycophenolate mofetil in patients with autoimmune diseases compared renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.1.7

Determination of mycophenolic acid and its phenol glucuronide metabolite in human plasma and urine by high-performance liquid chromatography

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901907

Mycophenolate mofetil therapy in lupus nephritis: clinical observations.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901907

The Impact of UGT1A8, UGT1A9, and UGT2B7 Genetic Polymorphisms on the Pharmacokinetic Profile of Mycophenolic Acid After a Single Oral Dose in Healthy Volunteers

29 October 2018

1 reference

12 December 2020

The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide

1 reference

12 December 2020

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

1 reference

12 December 2020

Role of parathyroid hormone in the downregulation of liver cytochrome P450 in chronic renal failure

1 reference

12 December 2020

Identifiers

DOI

10.1592/PHCO.29.1.7

1 reference

30 July 2017

1 reference

30 July 2017

1 reference